| CYHS2403753 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | | | | view |
| CYHS2403752 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | | | | view |
| CYHS2403754 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | | | | view |
| CYHS2401380 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-05-09 | | Chengdu Hengrui Pharmaceutical Co Ltd | | | view |
| CYHS2302990 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2023-11-03 | | Guangdong Pidi Pharmaceutical Co Ltd | | | view |
| CYHS2302442 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2023-09-11 | | Tonghua Wantong Pharmaceutical STOCK Co Ltd | | | view |
| CYHS2201243 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2022-08-05 | | Zhejiang Hisoar Pharmaceutical Co Ltd | | | view |
| CYHB2250454 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2022-07-21 | | Beijing Beilu Pharmaceutical Co Ltd | | | view |
| JYHZ2100648 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | License Renew | 2021-10-12 | | | | | view |
| JYHZ2100647 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | License Renew | 2021-10-12 | | | | | view |
| CYHS2101284 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2021-06-11 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYHB2101115 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2021-04-14 | | Beijing Foyou Pharma Co Ltd | | | view |
| CYHB2101117 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2021-04-14 | | Beijing Foyou Pharma Co Ltd | | | view |
| JYHB2002634 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-12-21 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Filed | 2021-01-06 | view |
| JYHB2002633 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-12-21 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Filed | 2021-01-06 | view |
| CYHB2009980 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-12-03 | 北京北陆药业股份有限公司 | Beijing Beilu Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| JYHB2000594 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-05-18 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Filed | 2020-06-03 | view |
| JYHB2000595 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-05-18 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Filed | 2020-06-03 | view |
| CYHB1950967 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-01-07 | 北京福元医药股份有限公司 | Beijing Foyou Pharma Co Ltd | Certificate Issued | 2020-10-21 | view |
| CYHB1950966 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2020-01-07 | 北京福元医药股份有限公司 | Beijing Foyou Pharma Co Ltd | Certificate Issued | 2020-10-21 | view |
